360 related articles for article (PubMed ID: 23179779)
1. A physiologically based pharmacokinetic model of the minipig: data compilation and model implementation.
Suenderhauf C; Parrott N
Pharm Res; 2013 Jan; 30(1):1-15. PubMed ID: 23179779
[TBL] [Abstract][Full Text] [Related]
2. Application of the Tissue Composition-Based Model to Minipig for Predicting the Volume of Distribution at Steady State and Dermis-to-Plasma Partition Coefficients of Drugs Used in the Physiologically Based Pharmacokinetics Model in Dermatology.
Poulin P; Collet SH; Atrux-Tallau N; Linget JM; Hennequin L; Wilson CE
J Pharm Sci; 2019 Jan; 108(1):603-619. PubMed ID: 30222978
[TBL] [Abstract][Full Text] [Related]
3. Utility of PBPK Absorption Modeling to Guide Modified Release Formulation Development of Gaboxadol, a Highly Soluble Compound With Region-Dependent Absorption.
Kesisoglou F; Balakrishnan A; Manser K
J Pharm Sci; 2016 Feb; 105(2):722-728. PubMed ID: 26457884
[TBL] [Abstract][Full Text] [Related]
4. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
[TBL] [Abstract][Full Text] [Related]
5. Organ data from the developing Göttingen minipig: first steps towards a juvenile PBPK model.
Van Peer E; Downes N; Casteleyn C; Van Ginneken C; Weeren A; Van Cruchten S
J Pharmacokinet Pharmacodyn; 2016 Apr; 43(2):179-90. PubMed ID: 26687458
[TBL] [Abstract][Full Text] [Related]
6. Identification of intestinal loss of a drug through physiologically based pharmacokinetic simulation of plasma concentration-time profiles.
Peters SA
Clin Pharmacokinet; 2008; 47(4):245-59. PubMed ID: 18336054
[TBL] [Abstract][Full Text] [Related]
7. Utility of Göttingen minipigs for Prediction of Human Pharmacokinetic Profiles After Dermal Drug Application.
Yamamoto S; Karashima M; Sano N; Fukushi C; Tohyama K; Arai Y; Hirabayashi H; Amano N
Pharm Res; 2017 Nov; 34(11):2415-2424. PubMed ID: 28828717
[TBL] [Abstract][Full Text] [Related]
8. Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation Approaches: A Systematic Review of Published Models, Applications, and Model Verification.
Sager JE; Yu J; Ragueneau-Majlessi I; Isoherranen N
Drug Metab Dispos; 2015 Nov; 43(11):1823-37. PubMed ID: 26296709
[TBL] [Abstract][Full Text] [Related]
9. In Vitro-In Vivo Correlation Using In Silico Modeling of Physiological Properties, Metabolites, and Intestinal Metabolism.
Choi SM; Kang CY; Lee BJ; Park JB
Curr Drug Metab; 2017; 18(11):973-982. PubMed ID: 29086683
[TBL] [Abstract][Full Text] [Related]
10. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.
Johnson TN; Rostami-Hodjegan A
Paediatr Anaesth; 2011 Mar; 21(3):291-301. PubMed ID: 20497354
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
Peters SA
Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
[TBL] [Abstract][Full Text] [Related]
12. A paradigm shift in pharmacokinetic-pharmacodynamic (PKPD) modeling: rule of thumb for estimating free drug level in tissue compared with plasma to guide drug design.
Poulin P
J Pharm Sci; 2015 Jul; 104(7):2359-68. PubMed ID: 25943586
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics during therapeutic hypothermia in neonates: from pathophysiology to translational knowledge and physiologically-based pharmacokinetic (PBPK) modeling.
Leys K; Stroe MS; Annaert P; Van Cruchten S; Carpentier S; Allegaert K; Smits A
Expert Opin Drug Metab Toxicol; 2023; 19(7):461-477. PubMed ID: 37470686
[TBL] [Abstract][Full Text] [Related]
14. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of intravenous pharmacokinetics in Göttingen minipig and clearance prediction using established
Langthaler K; Jones CR; Christensen RB; Eneberg E; Brodin B; Bundgaard C
Xenobiotica; 2022 Jun; 52(6):591-607. PubMed ID: 36000364
[TBL] [Abstract][Full Text] [Related]
16. Early identification of drug-induced impairment of gastric emptying through physiologically based pharmacokinetic (PBPK) simulation of plasma concentration-time profiles in rat.
Peters SA; Hultin L
J Pharmacokinet Pharmacodyn; 2008 Feb; 35(1):1-30. PubMed ID: 17963025
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Pharmacokinetics in the Göttingen Minipig with Reference Human Drugs: An In Vitro and In Vivo Approach.
Lignet F; Sherbetjian E; Kratochwil N; Jones R; Suenderhauf C; Otteneder MB; Singer T; Parrott N
Pharm Res; 2016 Oct; 33(10):2565-79. PubMed ID: 27469324
[TBL] [Abstract][Full Text] [Related]
18. [Progress in methodology of establishing physiologically based pharmacokinetic models].
Jin YW; Ma YM
Yao Xue Xue Bao; 2014 Jan; 49(1):16-22. PubMed ID: 24783500
[TBL] [Abstract][Full Text] [Related]
19. Human plasma concentrations of cytochrome P450 probe cocktails extrapolated from pharmacokinetics in mice transplanted with human hepatocytes and from pharmacokinetics in common marmosets using physiologically based pharmacokinetic modeling.
Utoh M; Suemizu H; Mitsui M; Kawano M; Toda A; Uehara S; Uno Y; Shimizu M; Sasaki E; Yamazaki H
Xenobiotica; 2016 Dec; 46(12):1049-1055. PubMed ID: 26916082
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional pharmacokinetic analogs for physiologically based pharmacokinetic (PBPK) model evaluation.
Ellison CA
Regul Toxicol Pharmacol; 2018 Nov; 99():61-77. PubMed ID: 30201539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
